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Introduction
Glomerulonephritis (GN), a common cause of endstage renal failure worldwide, is believed to result from immunologically induced inflammatory injury in the glomerulus (1) . Some cases result from autoimmune responses to glomerular antigens, such as glomerular basement membrane (GBM), and thus are autoimmune diseases in nature (2, 3) .
Historically, the involvement of the immune system in GN was first shown by the demonstration of deposits of Ab within glomeruli (2, 4) . This influenced early ideas to such an extent that it was thought that all types of GN could be explained by Ab-mediated mechanisms, either by a direct reaction with intrinsic glomerular antigen, such as anti-GBM Ab, or by the deposition of circulating immune complexes as seen in systemic lupus erythematosus (SLE) (2) (3) (4) (5) (6) . However, the participation of Ab and associated pathways alone cannot fully explain many human GN cases or some aspects of the pathways in experimental and human GN (7, 8) .
T cell-mediated cellular immunity has long been suspected to be potentially the most important mediator of GN (8) . Besides participating as helper cells in T cell-dependent Ab response to renal autoantigens, T cells may be directly involved in glomerular damage. Early evidence showed T cells were actually present in the glomerulus in a variety of human and experimental GN (9) (10) (11) . Those glomerular-infiltrating T cells may have been activated, as revealed by their expression of IL-2 receptor and various T cell cytokines (12) . The contribution of T cells to GN, especially the proliferative/crescentic type, has been investigated in animal models either lacking T cells or with interrupted B7/CD28 costimulation pathway (13) (14) (15) . In a mouse lupus model, the mice without secreted Ab developed GN, suggesting the direct involvement of T and/or B cells (16) .
One of the most significant questions for the T cell involvement in GN, however, has been whether antigen-specific CD4 + T cells per se could initiate glomerular injury. A weak T cell proliferative response specific to a GBM antigen has been found in the peripheral blood in anti-GBM disease patients (17) . Whether such a weak response is a true reflection of a T cell-mediated attack in the glomerulus remains unclear. In a chicken model, mononuclear cells from GBM-primed chicks transferred GN in naive animals (18) . Collagen 4α3 chains (Col4α3), which is a unique component of GBM and alveolar basement membrane, has been identified as autoantigen for Goodpasture syndrome (3, 19, 20) . Recently, several excellent rodent models have been developed based on this antigen (21, 22) . Susceptibility to anti-GBM GN induced by Col4α3 has been linked to the MHC class Ab-mediated mechanisms have been considered the major causes of glomerulonephritis (GN). However, recent studies suggest that T cells may be more important in mediating GN. To investigate the effects of antigen-specific CD4 + T cells, we generated Th1 cell lines specific for this antigen from rats that had been immunized with a recombinant form of the glomerular basement membrane (GBM) antigen, Col4α3NC1. Upon the transfer of in vitro-activated T cell lines to pertussis toxin-primed, naive syngeneic rats, the recipients developed severe proteinuria/albuminuria, which plateaued after ∼35 days. Although no IgG binding to GBM or C3 deposition could be detected by immunofluorescence, five out of eleven rats exhibited severe GN, as judged by the formation of characteristic crescent-shaped lesions in the glomerluli, whereas the others exhibited modest GN. Thus Col4α3NC1-specific T cells directly initiated glomerular injury in the recipients. One notable difference from GN induced by active immunization was a T cell infiltration in the renal interstitium, which affected some tubules. We therefore injected fluorescence-labeled Col4α3NC1-specific into naive rats, and we found that they were enriched 4.5-fold in the kidney cortex relative to nonspecific control T cells 24 hours later. Many of the T cells were located in the Bowman's space and had a flattened shape, suggesting that the primary target for the T cells was in or adjacent to the Bowman's capsule.
II gene in a murine model (23) . However, it is unclear whether T cells are merely helper cells in Ab responses, or if they directly initiate the glomerular injury.
To address this question, we have developed a rat model for anti-GBM GN based on noncollagen domain 1 of Col4α3 (Col4α3NC1). We have shown previously the disassociation between anti-GBM Ab and disease severity (24) . In the present study, we were able to demonstrate that GN could be induced by transferring Col4α3NC1-specific CD4 + T cells. Thus, antigen-specific CD4 + T cells per se are sufficient to cause glomerular injury.
Methods
Ab's. Biotin-labeled anti-rat CD3 (G.4.18), biotinlabeled anti-rat CD11b/c, phycoerythrin-labeled (PE-labeled) anti-rat CD4 (OX35), FITC-labeled antirat IFN-γ (DB-1), PE-labeled anti-rat IL-4 (OX-81) Ab's, FITC-labeled rat IgG-1, and PE-labeled rat IgG-2 isotype controls were obtained from PharMingen (San Diego, California, USA). FITC-labeled anti-rat IgG, FITC-labeled anti-rat IgM, peroxidase-labeled anti-rat IgG Ab's, and purified rat IgG were obtained from Southern Biotechnology Associates (Birmingham, Alabama, USA), and FITC-anti-rat C3 Ab was obtained from ICN Radiochemicals Inc. (Costa Mesa, California, USA). Biotin-or FITC-labeled Ab SR-13 and SR-6 were kind gifts from Y. Sado, Okayama University, Okayama City, Japan. SR-13 reacts mainly with GBM, whereas SR-6 reacts with both GBM and tubular basement membrane (TBM).
Immunization and GN evaluation. Female Wistar-Kyoto rats (4-6 weeks of age) were purchased from Harlan (Indianapolis, Indiana, USA). The rats were maintained in the animal facility at the University of Texas Houston Health Science Center and allowed to acclimate for 3 days. Rats were immunized with 300 µg of recombinant Col4α3NC1 emulsified in CFA in one hind footpad and at the base of the tail (24) . Lymphocytes were isolated from the immunized rat for generating T cell lines. Rats immunized with CFA alone served as controls. GN was evaluated by proteinuria and renal histopathology. Random urine samples were monitored daily by Multstix (Bayer Corp., Pittsburgh, Pennsylvania, USA), and the selected samples were analyzed in the Clinical Chemistry Laboratory, Texas Children's Hospital, Baylor College of Medicine starting at day 14. Urine albumin was semiquantitated by 12% SDS-PAGE (2 µl urine/lane) using BSA as a standard.
The experimental animals were sacrificed as indicated. Renal tissues fixed in Bouin's fixative were used for hematoxylin and eosin staining and fixed in 10% formalin for periodic acid-Schiff, trichrome, or Jones's staining. Part of the renal tissue was snap-frozen in liquid nitrogen for direct immunofluorescence staining. Based on the percentage of glomeruli with crescent formation, GN was graded as severe (>50%), modest (<50% but >5%), or normal (<5%). Infiltrating T cells were identified by immunoperoxidase staining with anti-rat CD3 mAb, monocytes/macrophages by anti-rat CD11b/c mAb, and B cells by immunofluorescent staining with anti-rat IgM/IgG.
Lymphocyte proliferation assay and T cell line generation. Lymphocyte proliferation assay (LPA) was carried out as described previously (24) . Briefly, T cells and irradiated thymocytes (at 1:1 ratio) were cultured in 96-well plates at 4 × 10 5 cells/well in 200 µl of complete T cell medium. Digested rat GBM proteins (24) or rCol4α3NC1 (0.1-10 µg/ml) were added to each well in triplicate, and purified protein derivative (PPD) was used as positive control. The cells were incubated at 37°C in a humidified, 5% CO 2 atmosphere for 72 hours, pulsed with 3 H-thymidine, 0.5 µCi/well, for 18 hours (ICN Radiochemicals Inc.), and harvested onto glass fiber filters using a semiautomatic cell harvester. The incorporated radioactivity was measured by a liquid scintillation counter (Beckman Instruments Inc., Fullerton, California, USA). The results were expressed as mean triplicate cpm with antigen minus mean triplicate cpm without antigen (∆cpm).
A similar protocol was used to stimulate T cells for generating T cell lines. Lymphocytes isolated from the immunized rats were stimulated by rCol4α3NC1 for 4 days and harvested by two gradient centrifugations with Histopaque (Sigma Chemical Co., St. Louis, Missouri, USA) to completely remove dead cells and remaining rCol4α3NC1. The cells were allowed to rest for 7 days in the presence of 2.5% supernatant of Con-A-stimulated (Sigma Chemical Co.) normal rat splenic cells. Based on our experience, addition of irradiated syngeneic thymocytes during rest was necessary to exhaust potential self-reactive T cells. After the first stimulation, the T cells were stimulated in the presence of irradiated syngeneic thymocytes.
Cellular composition of T cell lines was determined by two methods. First, the cells were stained by anti-CD4-PE and anti-rat IgM/IgG-FITC Ab's followed by flow cytometry analyses (FACSCalibur; Becton Dickinson Immunocytometry Systems, San Jose, California, USA). Second, supernatants after each stimulation were collected for detecting Ab activities by Western blot analysis and rat IgG by ELISA using purified rat IgG as a standard as described (24) .
After more than three cycles of stimulation, T cell lines were used for transfer. The naive recipient received 100 µl of pertussis toxin (10 µg/rat, a kind gift from K. Tung, University of Virginia, Charlottesville, Virginia, USA) 24 hours before experiments. T cells (60 × 10 6 in HBSS) were transferred into naive recipients by intravenous injection.
Cytokine detection by intracellular cytokine staining and RT-PCR. T cells at the end of the rest period were stimulated by a combination of PMA (500 nM) (AG Scientific, San Diego, California, USA) and ionomycin (32 nM) (Fisher Scientific Co., Pittsburgh, Pennsylvania, USA) for 8 hours, and GolgiStop (PharMingen) was added to the incubation for 4 hours. A kit from PharMingen was used for intracellular cytokine staining with FITC-labeled anti-rat INF-γ and PE-labeled anti-rat IL-4 Ab's. A small portion of unfixed T cells was stained by PE-labeled anti-rat CD4 Ab. The samples were analyzed by flow cytometry. Cytokines were also determined by RT-PCR. One million T cells at rest or harvested after antigenspecific stimulation were used to isolate total RNA using a kit from Ambion Inc. (Austin, Texas, USA), and cDNA was synthesized by using an RT-PCR kit (Sigma Chemical Co.). PCR was carried out to detect expression of IL-4 and INF-γ following a published method (25) . PCR products were visualized by ethidium bromide staining after rapid agarose gel electrophoresis (RAGE) electrophoresis.
T cell labeling experiments. Activated T cells were labeled by CFDA-SE (5/6-carboxyfluorescein diacetate succinimidyl ester; 37.5 µM in DMSO) (Molecular Probes Inc., Eugene, Oregon, USA) as described previously (26) . The labeled cells were injected into pertussis toxin-primed rats (60 × 10 6 cells/rat). As a control, T cells from CFA-immunized rats were activated by Con-A, labeled, and transferred to pertussis-primed rats. The recipients were sacrificed 24 hours later. Peripheral white blood cells were isolated. Different organs including lung, gut, liver, pancreas, spleen, lymph nodes, thymus, and kidney were dissected out for (a) isolation of cells for flow cytometry by digestion with collagenase D (Roche Molecular Biochemicals, Indianapolis, Indiana, USA) following a published method (27) and (b) observation of frozen sections using a fluorescent microscope. Some cells remained in the culture as a positive control. Labeled cells in the kidney cortex were counted in more than ten serial frozen sections (5 µm). The areas of the section were calculated by a computer image-analyzing program (Alpha Innotech, San Leandro, California, USA). The density of the labeled cells in the cortex was calculated as follows: cell density (cells/mm 3 ) = labeled cell number/section area (mm 2 ) × 0.005 mm × section number.
The data were analyzed by t test. Some sections were stained by an anti-GBM Ab, SR-13, to reveal the location of the labeled T cells.
Results

Characterization of Col4α3NC1-specific T cell lines.
We have shown previously that T cells from rCol4α3NC1-immunized rats responded not only to rCol4α3NC1, but also to the digested GBM proteins (24) . The antigen specificity of the T cell lines (three in total) generated from rCol4α3NC1-immunized rats was determined after each stimulation cycle. It was not surprising to find that T cell lines reacted with both rCol4α3NC1 and digested GBM proteins (Figure 1 ). Flow cytometry showed that the T cell lines after the third stimulation cycle were composed of more than 98% CD4 + T cells with essentially no IgG/IgM-positive cells (Figure 2a ). Supernatants collected after each stimulation were analyzed for rat IgG concentration and Ab to rCol4α3NC1. Rat IgG, as well as Ab to rCol4α3NC1, could be well detected in the supernatants after the first stimulation, but quickly became undetectable after third stimulation (Figure 2b ). The undetectable rat IgG and Ab activity in the supernatants confirmed the absence of antigen-specific B cells in the T cell lines.
Cytokine phenotype of the T cell lines after the third stimulation was characterized by intracellular cytokine staining. The cytokine phenotype was first determined by RT-PCR after stimulation by rCol4α3NC1. Only IFN-γ mRNA was detected in the rCol4α3NC1-specific T cell lines after stimulation ( Figure 3a) . As shown in Figure 3b , a T cell population that secreted IFN-γ, but not IL-4, was detected in the T cell lines after activation by mitogens, indicating a Th1 phenotype. Transfer of rCol4α3NC1-specific CD4 + T cells induces proteinuria and GN in naive recipients. Three characterized rCol4α3NC1-specific, CD4 + T cell lines of Th1 type were transferred into 11 syngeneic rats that had received pertussis toxin 24 hours earlier. Mild proteinuria became detectable in the T cell recipients around 10 to 12 days after cell transfer. Two out of 11 returned to normal without further development, while, in the other nine, proteinuria persisted and gradually reached a plateau, ranging from 1,100 to over 2,500 mg/dl around day 35 to 40 ( Figure 4a ). SDS-PAGE analyses of the urine samples revealed severe albuminuria ( Figure  4b ). The proteinuria was accompanied by severe hematuria. Severe proteinuria/albuminuria indicated the glomerular damage in the T cell recipients. However, the development of proteinuria/hematuria in the T cell recipients was much slower as compared with the rats actively immunized with rCol4α3NC1 in which proteinuria rapidly plateaued around 24 days after immunization (24) . No T cell recipients died during the experimental period, as compared with 30% mortality in rCol4α3NC1-immunized rats around 35 days (24) .
Rats were sacrificed around 65 days after the T cell transfer. Kidneys from five rats with proteinuria above 1,500 mg/dl appeared pale and enlarged, while the kidneys from the other six had normal size and color. Histopathology of the renal tissues demonstrated similar glomerular damage as seen in rCol4α3NC1-immunized rats (24) (Figure 5a ). The severity of GN was correlated with the amount of proteinuria and abnormal gross appearance. Five kidneys with abnormal appearance showed severe GN (50-65% of glomeruli with crescent formation). In contrast, the kidneys from the four rats with proteinuria lower than 1,500 mg/dl had modest GN in which crescent formation affected less than 25% of glomeruli. Kidneys from the two without significant proteinuria had no sign of GN. In severe and modest GN, glomeruli with crescents, as well as some without, demonstrated segmental fibrin deposition and necrosis. Jones's staining demonstrated deposition of the matrix proteins around glomeruli and irregular, thickened GBM (data are not shown). Electron microscope (EM) studies especially revealed significant loss of podocyte processes ( Figure 6 ). Examination of the other organs (except for the lung, which is currently under pathological evaluation) in two T cell recipients with severe GN did not reveal pathological changes. As controls, T cells isolated from CFA-immunized rats were either stimulated with Con-A or PPD. Transfer of those T cells did not cause any pathological changes or proteinuria in six rats. Occasionally, clusters of T cells were found to surround blood vessels. We concluded that transfer of Col4α3NC1-specific T cells induced GN in syngeneic naive recipients.
Infiltration of mononuclear cells in the interstitial tissue in the T cell recipients.
Widely distributed leukocyte infiltration in the interstitial tissues, though also seen in rats immunized with rCol4α3NC1, was significant in the T cell recipients (Figure 5a ). The cellular composition of the infiltrates was investigated. Morphologically, the infiltrates consisted of mononuclear cells essentially free of polymorphonuclear leukocytes (Figure 5a ). Immunohistochemistry demonstrated that the infiltrating cells were mainly CD3 + T cells (56.1% ± 5.9%) (Figure 5b ). Infiltration of monocytes in both the glomeruli and interstitium was confirmed by anti-CD11b/c staining. Interestingly, glomerular infiltrating cells were mainly monocytes/macrophages (CD11b/c + ) and clustered
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The within the Bowman's capsule (Figure 5c ). Surface IgG/M + B cells were not found in any leukocyte infiltrates. The infiltrates were frequently centered around glomeruli. Tubular injury was also present. Interstitial infiltration by mononuclear cells was not observed in the control rats that received CFA T cells.
Absence of IgG binding/C3 deposition in GBM of the T cell recipients.
That activation of self-reactive T cells may trigger autoantibody production through T to B cell epitope spreading is well recognized (28) . It was possible that transfer of Col4α3NC1-specific T cells might have led to production of anti-GBM Ab. To determine whether anti-GBM Ab existed in the T cell recipients, direct immunofluorescence on the recipients' renal tissues was used to detect IgG/IgM bound to the GBM or deposition of C3 (Figure 7 ). Neither binding of IgG nor deposition of C3 was observed in any T cell recipients (Figure 7b) . The IgM staining, with an obvious "crescent" shape, was localized within the crescentic lesions of affected glomeruli; however, linear staining was not observed (Figure 7a ). We concluded that the detected IgM was not anti-GBM Ab, but serum IgM nonspecifically trapped in the fibrin deposits of crescentic lesions. Since there was no evidence of linear staining for IgG or IgM, it was unlikely that anti-GBM Ab was produced in the T cell recipients. Thus the antigen-specific T cells were responsible for glomerular injury by direct targeting of glomerular antigen.
Tissue distribution of transferred T cells. We next asked whether antigen-specific T cells were able to target glomeruli and initiate glomerular inflammation. Col4α3NC1-specific T cells were activated in vitro and labeled by CFDA-SE before transfer. Another T cell line from CFA-immunized rats was stimulated by Con-A and labeled as a control. The recipients, having received either labeled Col4α3NC1-specific or control T cells, were sacrificed 24 hours later. Distributions of the labeled cells in the tissues of recipients were investigated. Flow cytometry analyses did not reveal significant differences in densities (percentage) of labeled cells between rCol4α3 T cells and CFA T cells in most locations (Table 1) . One exception was in the lung, in which rCol4α3 T cells were twice as dense as CFA T cells. Although the density of rCol4α3NC1 T cells in the whole kidney was slightly higher than that of CFA T cells, there was no significant difference. However, fluorescence microscopy showed that rCol4α3NC1 T cells in the kidney cortex were enriched 4.5-fold in comparison with CFA T cells (Figure 8a ). More significantly, the two cell lines differed greatly in cell shape and distribution. CFA T cells were distributed evenly in the interstitial tissue, as well as within the glomerulus. Most of the infiltrating cells were round, similar to the cells found in other organs or in the culture. On the other hand, most of the rCol4α3NC1-specific T cells (65%) were found within the Bowman's space or surrounding the base of tubules. These T cells became elongated and/or flattened ( Figure 8, b and c) .
Discussion
The results from the present study demonstrate that transfer of GBM-specific CD4 + T cells was sufficient to induce GN in naive animals. We further showed that pathogenic features of GN induced by T cell transfer were similar to that induced by active immunization with rCol4α3NC1 (24) . First, severe proteinuria/albuminuria developed in both cases. It is widely accepted that albuminuria is one of the most critical clinical indices for glomerular damage in both human disease and animal models. Second, histopathology revealed glomerular damage, characterized mainly by crescent formation, in the kidney of the T cell recipients. Traditionally, Ab and its associated pathways have been considered the most important cause of GN (1). To our knowledge, this study is the first direct evidence to support the hypothesis that GBM antigenspecific CD4 + T cells per se are able to initiate glomerular injury that leads to GN.
The next question is whether B cells are involved in GN pathogenesis in our passive-transfer model. B cells might be involved in several ways. First, antigen-specific B cells may produce anti-GBM Ab, which in turn causes glomerular injury. Since we did not detect any anti-GBM Ab in the T cell recipients with severe GN, it seems unlikely that B cells might be involved in this way. Second, B cells might participate in GN pathogenesis as antigen-presenting cells (APCs). This has been documented in a few T cell-mediated autoimmune disease models (29) (30) (31) . In general, some believe that B cells may act as APCs in the initial activation of naive autoreactive T cells. Thus it is important to test whether B cells may play roles as APCs if an autoimmune disease is induced by active immunization. The situation in the disease induced by transferring T cells, however, is very different. Because the transferred T cells are not naive and have been activated in vitro, they have rendered the ability to target the autoantigen without further activation by the recipients' endogenous APCs, including B cells. Third, B cells might participate in GN pathogenesis as infiltrating leukocytes (31) . However, no B cells were observed in any leukocyte infiltrates in the kidney of the T cell recipients in our study. Therefore, it is unlikely that endogenous B cells might have been involved in GN pathogenesis in our model. T cell-mediated immunity has long been suspected to be the most important mediator of GN (8) . T cells may be involved in the pathogenesis of GN at three different levels. First, T cells may participate as helper cells in T cell-dependent Ab response to renal autoantigens. It has been shown that several autoantibodies to glomerular antigens are T cell independent (32) . Second, T cells may cause glomerular damage as infiltrating leukocytes. Several studies have demonstrated that CD4 + and CD8 + T cell populations may be required in Ab-mediated GN (14) . In a mouse lupus model, the mice without secreted Ab still developed GN, suggesting direct involvement of T and/or B cells (16) . Third, antigen-specific T cells may directly target glomerular antigen to initiate damage. The potential involvement of T cells in GN has been a subject of significant interest. Although this mechanism has been suspected, evidence to support it, despite development of several excellent animal models, has been lacking (21) (22) (23) 33) . In those models, the antigens were either purified native GBM proteins or recombinant proteins expressed in mammalian cells that also closely resembled the native GBM protein. Immunization with those antigens always led to production of autoantibodies to host's GBM. There was little analysis of the T cell responses in those models. Therefore, it was difficult to determine which mechanism, Ab, T cells, or both, mediated the glomerular injury in those models.
Some studies have focused more on the role of antigen-specific T cells in anti-GBM GN. Disease susceptibility has been strongly linked to MHC class II, suggesting the potential roles of the antigen-specific T cells in glomerular damage (23) . Transfer of unstimulated splenocytes from the immunized animals into naive recipients induced a mild GN, as well as anti-GBM Ab (23) . An early study also showed that transfer of mononuclear cells from chicks immunized with isolated GBM induced GN in naive animals (18) . Although these models used cell transfer to induce GN, it was difficult to interpret data due to the following reasons. First, transferred cells might have included antigenspecific B cells, which may produce significant autoantibody in vivo. Actually, our study showed that antigenspecific B cells probably could survive and secrete Ab for up to two cycles of stimulation. Second, specificity of T cells were never determined. Thus, the cell transfer experiments in those studies might suggest, but did not prove, that antigen-specific T cells per se could induce glomerular damage. The most unique feature of our model, therefore, was successful generation of CD4 + T cell lines, which recognized not only recombinant Col4α3NC1, but also digested rat GBM proteins. With this unique tool, we were able to address the question of whether antigen-specific CD4 + T cells could transfer the diseases in the syngeneic naive animals. Recently, we have identified two peptides derived from Col4α3NC1 that encode T cell epitopes. Immunization with those short peptides also induced similar
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The Despite the similarity between GN induced by T cell transfer and active immunization, several differences were significant. First, there was much more widely distributed mononuclear infiltration, mainly T cells, in the renal interstitial tissue of the T cell recipients. Such infiltrates may cause damage to tubules. Second, it took a much longer period for the T cell recipients to develop severe proteinuria than it did in those immunized with rCol4α3NC1. Currently, it is not understood what causes these differences. One explanation may lie in the source of antigen-specific T cells. Active immunization may provide a continuous supply of antigen-specific T cells. Thus nearly all glomeruli could be attacked by the T cells over a certain period. While in the case of T cell transfer only very few antigenspecific T cells may have a chance to infiltrate into the kidney to reach the target, most of them die out in other tissues. Thus T cell transfer may induce inflammation in a limited number of glomeruli. Unlike some autoimmune disease models, such as experimental allergic encephalomyelitis in which a localized injury to CNS may still lead to significant clinical manifestations, damage to a limited number of glomeruli in GN may not result in clinically significant manifestations. If transferred T cells were able to target only a few glomeruli, the next question is why the T cell recipients eventually develop severe proteinuria and glomerular damage. Occurrence of "T cell epitope spreading" during GN pathogenesis may be an explanation (34) . The endogenous self-reactive T cells may be activated within the inflamed glomeruli and/or in the interstitial infiltrates. Proteinuria and a large-scale glomerular damage might be caused by the second-wave attack by endogenously activated T cells. However, this mechanism needs to be determined in the future.
The observation that GBM-specific CD4 + T cells can directly cause glomerular injury gives rise to the question, which types of cells may serve as APCs in glomeruli for antigen-specific CD4 + T cells? Several early studies have investigated the MHC class II (Ia) expression in the rat glomerulus and found that the cell population expressing MHC class II was localized to the renal mesangium (35, 36) . Such MHC class II expression is enhanced by various reagents such as IFN-γ (37). Cultured mesangial cells were able to stimulate sensitized lymphocytes to proliferate, though the nature of proliferation is unclear (38) . By tracing labeled antigen-specific T cells, however, we found that the T cells may invade glomeruli through the Bowman's capsule. At present, it is not clear to which types of cells the T cells adhere; however, mesangial cells may not necessarily be the first target for T cells. This inference is partially supported by our observation that monocytes/macrophages clustered in the Bowman's space of the affected glomerulus (Figure 5c ). Our next goal is to identify the cells in glomeruli, which may serve as APCs for T cells.
What is the significance of the finding that antigenspecific CD4 + T cells per se also cause GN? Accumulating data showed that Ab-mediated mechanisms alone do not explain many aspects or cases of GN, either for human disease or animal models. For example, in rare cases of crescentic GN, neither immune complex, nor Ab to GBM, nor antineutrophil cytoplasm Ab's were found in patients (39) . Even in GN with the Ab's, it has been found that autoantibody titers failed to predict the severity of GN in many human patients (40) . Our finding could provide another explanation of those cases. Fully understanding the mechanism of T cell-mediated glomerular injury will be essential in designing new therapies for this human disease. Our model may serve as an excellent tool to explore T cell mechanisms in GN. 
